EP3190126A1
(en)
|
2000-05-26 |
2017-07-12 |
Immunex Corporation |
Use of interleukin-4 receptor (il-4r) antibodies and compositions thereof
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
ES2776657T3
(es)
*
|
2005-06-14 |
2020-07-31 |
Amgen Inc |
Formulaciones de proteínas autotamponantes
|
CA2622016A1
(en)
*
|
2005-09-09 |
2007-03-15 |
Imperial Innovations Limited |
Interferon lambda therapy for treatment of respiratory diseases
|
UA96139C2
(ru)
*
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитело к нейропилину-1 (nrp1)
|
CN101522716B
(zh)
*
|
2006-10-02 |
2013-03-20 |
瑞泽恩制药公司 |
抗人il-4受体的高亲和力人抗体
|
US7608693B2
(en)
*
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
ES2663080T3
(es)
|
2006-11-01 |
2018-04-11 |
Ventana Medical Systems, Inc. |
Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso
|
US7682789B2
(en)
*
|
2007-05-04 |
2010-03-23 |
Ventana Medical Systems, Inc. |
Method for quantifying biomolecules conjugated to a nanoparticle
|
ES2731432T3
(es)
|
2007-05-23 |
2019-11-15 |
Ventana Med Syst Inc |
Transportadores poliméricos para inmunohistoquímica e hibridación in situ
|
AU2008293425B2
(en)
*
|
2007-08-31 |
2014-09-18 |
Amgen Inc. |
Solid-state protein formulation
|
AU2008298904B2
(en)
|
2007-09-14 |
2014-10-16 |
Amgen Inc. |
Homogeneous antibody populations
|
EP2205280B1
(en)
|
2007-09-27 |
2019-09-04 |
Amgen Inc. |
Pharmaceutical formulations
|
EP2050764A1
(en)
*
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
WO2009064838A1
(en)
|
2007-11-15 |
2009-05-22 |
Amgen, Inc. |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
RU2490278C2
(ru)
*
|
2007-12-21 |
2013-08-20 |
Медиммун Лимитед |
ЭЛЕМЕНТ, СВЯЗЫВАЮЩИЙСЯ С α-РЕЦЕПТОРОМ ИНТЕРЛЕЙКИНА-4 (IL-4Rα)-173
|
US8092804B2
(en)
*
|
2007-12-21 |
2012-01-10 |
Medimmune Limited |
Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
|
EP2271674A2
(en)
*
|
2008-04-02 |
2011-01-12 |
Apogenix GmbH |
Binding agents directed against il-4 receptor for the treatment of tumors, inflammatory and immunological disorders
|
WO2009149013A2
(en)
|
2008-06-05 |
2009-12-10 |
Ventana Medical Systems, Inc. |
Compositions comprising nanomaterials and method for using such compositions for histochemical processes
|
US20130064834A1
(en)
|
2008-12-15 |
2013-03-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia using antibodies to pcsk9
|
US9662271B2
(en)
|
2009-10-23 |
2017-05-30 |
Amgen Inc. |
Vial adapter and system
|
USPP22463P3
(en)
*
|
2010-02-16 |
2012-01-17 |
Menachem Bornstein |
Gypsophila plant named ‘Pearl Blossom’
|
PT2539366T
(pt)
*
|
2010-02-26 |
2018-02-13 |
Bioarctic Neuroscience Ab |
Anticorpos de ligação a protofibrilas e sua utilização em métodos terapêuticos e diagnósticos para a doença de parkinson, demência com corpos de lewy e outras alfa-sinucleinopatias
|
EA032537B1
(ru)
|
2010-06-07 |
2019-06-28 |
Эмджен Инк. |
Способ работы устройства для доставки лекарственного средства
|
NZ605449A
(en)
|
2010-07-09 |
2015-03-27 |
Genentech Inc |
Anti-neuropilin antibodies and methods of use
|
WO2012135315A1
(en)
|
2011-03-31 |
2012-10-04 |
Amgen Inc. |
Vial adapter and system
|
LT2699293T
(lt)
|
2011-04-20 |
2019-04-25 |
Amgen Inc. |
Automatinio purškimo prietaisas
|
CN103842383B
(zh)
|
2011-05-16 |
2017-11-03 |
健能隆医药技术(上海)有限公司 |
多特异性fab融合蛋白及其使用方法
|
EP3536712B1
(en)
|
2011-09-16 |
2023-05-31 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9)
|
EP3335747B1
(en)
|
2011-10-14 |
2021-04-07 |
Amgen Inc. |
Injector and method of assembly
|
CN104302664B
(zh)
*
|
2012-03-14 |
2021-11-26 |
瑞泽恩制药公司 |
多特异性抗原结合分子及其用途
|
ES2900342T3
(es)
|
2012-08-21 |
2022-03-16 |
Sanofi Biotechnology |
Métodos para tratar o prevenir el asma administrando un antagonista de IL-4R
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
ES2780395T3
(es)
|
2012-11-21 |
2020-08-25 |
Amgen Inc |
Dispositivo de administración de fármacos
|
CA2916421A1
(en)
|
2013-03-14 |
2014-09-25 |
Bayer Healthcare Llc |
Monoclonal antibodies against antithrombin beta complexed with heparin
|
US10492990B2
(en)
|
2013-03-15 |
2019-12-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
US9708375B2
(en)
|
2013-03-15 |
2017-07-18 |
Amgen Inc. |
Inhibitory polypeptides specific to WNT inhibitors
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
CN113559363B
(zh)
|
2013-03-22 |
2023-10-31 |
美国安进公司 |
注射器及装配方法
|
US10111953B2
(en)
|
2013-05-30 |
2018-10-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
|
TWI633891B
(zh)
*
|
2013-06-04 |
2018-09-01 |
再生元醫藥公司 |
藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
|
JP6463351B2
(ja)
|
2013-06-21 |
2019-01-30 |
サノフィ・バイオテクノロジー |
Il−4rアンタゴニストの投与により鼻茸を処置する方法
|
TWI682781B
(zh)
|
2013-07-11 |
2020-01-21 |
美商再生元醫藥公司 |
藉由投與il-4r抑制劑治療嗜酸性食道炎的方法
|
EP3712166A1
(en)
|
2013-09-05 |
2020-09-23 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
US11097055B2
(en)
|
2013-10-24 |
2021-08-24 |
Amgen Inc. |
Injector and method of assembly
|
JP7051293B2
(ja)
|
2013-10-24 |
2022-04-11 |
アムジエン・インコーポレーテツド |
温度感知制御を伴う薬剤送達システム
|
DE202014010499U1
(de)
|
2013-12-17 |
2015-10-20 |
Kymab Limited |
Targeting von humaner PCSK9 zur Cholesterinbehandlung
|
US8986691B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
US8980273B1
(en)
|
2014-07-15 |
2015-03-17 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
KR20220029765A
(ko)
|
2014-02-21 |
2022-03-08 |
사노피 바이오테크놀로지 |
Il-4r 길항제의 투여에 의한 천식의 치료 또는 예방 방법
|
CN106062000B
(zh)
|
2014-02-28 |
2021-05-28 |
瑞泽恩制药公司 |
通过施用il-4r拮抗剂治疗皮肤感染的方法
|
SG11201609219QA
(en)
|
2014-05-07 |
2016-12-29 |
Amgen Inc |
Autoinjector with shock reducing elements
|
WO2015175861A1
(en)
|
2014-05-16 |
2015-11-19 |
Amgen Inc. |
Assay for detecting th1 and th2 cell populations
|
KR102506249B1
(ko)
|
2014-06-03 |
2023-03-03 |
암겐 인코포레이티드 |
약물 전달 시스템 및 사용 방법
|
WO2016023916A1
(en)
|
2014-08-12 |
2016-02-18 |
Kymab Limited |
Treatment of disease using ligand binding to targets of interest
|
CA2957960C
(en)
|
2014-10-14 |
2023-08-22 |
Amgen, Inc. |
Drug injection device with visual and audible indicators
|
WO2016071701A1
(en)
|
2014-11-07 |
2016-05-12 |
Kymab Limited |
Treatment of disease using ligand binding to targets of interest
|
CN107206073A
(zh)
|
2014-11-14 |
2017-09-26 |
赛诺菲生物技术公司 |
通过施用il‑4r拮抗剂用于治疗伴随鼻息肉的慢性鼻窦炎的方法
|
EP3233159B1
(en)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
JP6716566B2
(ja)
|
2014-12-19 |
2020-07-01 |
アムジエン・インコーポレーテツド |
近接センサ付き薬物送達装置
|
ES2748750T3
(es)
|
2015-02-17 |
2020-03-17 |
Amgen Inc |
Dispositivo de administración de fármacos con sujeción asistida por vacío y/o realimentación
|
ES2905870T3
(es)
|
2015-02-27 |
2022-04-12 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
|
KR20180025865A
(ko)
|
2015-07-06 |
2018-03-09 |
리제너론 파마슈티칼스 인코포레이티드 |
다중특이적 항원 결합 분자 및 이의 용도
|
SG10202101105XA
(en)
|
2015-08-13 |
2021-03-30 |
Amgen Inc |
Charged depth filtration of antigen-binding proteins
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
CA3014202A1
(en)
|
2016-02-19 |
2017-08-24 |
Regeneron Pharmaceuticals, Inc. |
Methods for enhancing efficacy of a vaccine by administering an il-4r antagonist
|
EP3721922B1
(en)
|
2016-03-15 |
2022-05-04 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
EP3430058A4
(en)
|
2016-03-15 |
2019-10-23 |
Generon (Shanghai) Corporation Ltd. |
MULTISPECIFIC FAB FUSION PROTEINS AND USES THEREOF
|
US11352446B2
(en)
|
2016-04-28 |
2022-06-07 |
Regeneron Pharmaceuticals, Inc. |
Methods of making multispecific antigen-binding molecules
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
AU2017263558B2
(en)
|
2016-05-13 |
2022-12-22 |
Amgen Inc. |
Vial sleeve assembly
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
CN107474134B
(zh)
*
|
2016-06-08 |
2021-07-27 |
苏州康乃德生物医药有限公司 |
用于结合白细胞介素4受体的抗体
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
MA46098A
(fr)
|
2016-09-01 |
2019-07-10 |
Regeneron Pharma |
Méthodes de prévention ou de traitement de l'allergie par administration d'un antagoniste d'il-4 r
|
US10485844B2
(en)
|
2016-09-22 |
2019-11-26 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
|
MX2019003235A
(es)
|
2016-09-22 |
2019-07-08 |
Regeneron Pharma |
Metodos para tratar dermatitis atopica severa administrando un inhibidor de receptor de isoleucina-4.
|
MX2019004580A
(es)
|
2016-10-21 |
2019-08-12 |
Amgen Inc |
Formulaciones farmaceuticas y metodos para prepararlas.
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
TWI784988B
(zh)
|
2016-12-01 |
2022-12-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
JP7064501B2
(ja)
|
2017-02-17 |
2022-05-10 |
アムジエン・インコーポレーテツド |
無菌流体流路を備える薬物送達デバイスおよび関連する組立方法
|
AU2018221351B2
(en)
|
2017-02-17 |
2023-02-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
CA3050927A1
(en)
|
2017-03-06 |
2018-09-13 |
Brian Stonecipher |
Drug delivery device with activation prevention feature
|
IL268478B2
(en)
|
2017-03-07 |
2023-10-01 |
Amgen Inc |
Inserting a needle using super pressure
|
JP2020509837A
(ja)
|
2017-03-09 |
2020-04-02 |
アムジエン・インコーポレーテツド |
薬剤送達装置のための挿入機構
|
AU2018235928B2
(en)
|
2017-03-14 |
2023-09-21 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
CN110446512B
(zh)
|
2017-03-28 |
2022-03-18 |
美国安进公司 |
柱塞杆和注射器组件系统以及方法
|
SG11201909457XA
(en)
|
2017-04-13 |
2019-11-28 |
Regeneron Pharma |
Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding il33 and il1rl1
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
EP3634546A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Torque driven drug delivery device
|
MX2019015472A
(es)
|
2017-06-22 |
2020-02-19 |
Amgen Inc |
Reduccion del impacto/choque de la activacion del mecanismo.
|
WO2018237225A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
ELECTRONIC DRUG DELIVERY DEVICE COMPRISING A CAP ACTIVATED BY A SWITCH ASSEMBLY
|
EP3651832B1
(en)
|
2017-07-14 |
2023-12-13 |
Amgen Inc. |
Needle insertion-retraction system having dual torsion spring system
|
MA49626A
(fr)
|
2017-07-21 |
2020-05-27 |
Amgen Inc |
Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage
|
WO2019022951A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF
|
WO2019022950A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF
|
WO2019028367A1
(en)
|
2017-08-04 |
2019-02-07 |
Regeneron Pharmaceuticals, Inc. |
METHODS OF TREATING ESOPHAGITIS WITH ACTIVE EOSINOPHILES
|
EP3664863A2
(en)
|
2017-08-09 |
2020-06-17 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
MA49897A
(fr)
|
2017-08-18 |
2020-06-24 |
Amgen Inc |
Injecteur sur-corps avec patch adhésif stérile
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
CN111132711B
(zh)
|
2017-10-06 |
2022-07-01 |
安进公司 |
带有联锁组件的药物递送装置及相关组装方法
|
EP3694578A1
(en)
|
2017-10-09 |
2020-08-19 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
CA3079946A1
(en)
|
2017-10-30 |
2019-05-09 |
Sanofi Biotechnology |
Methods for treating or preventing asthma by administering an il-4r antagonist
|
WO2019090079A1
(en)
|
2017-11-03 |
2019-05-09 |
Amgen Inc. |
System and approaches for sterilizing a drug delivery device
|
WO2019089178A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
WO2019090303A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
RU2020113059A
(ru)
|
2017-11-07 |
2021-12-08 |
Хьюбит Дженомикс,Инк. |
Способ первичного предотвращения аллергических заболеваний у детей младенческого возраста с помощью специфичной иммуносупрессии иммуноглобулинов класса ige
|
CA3079665A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
WO2019099324A1
(en)
|
2017-11-16 |
2019-05-23 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
MX2020005066A
(es)
|
2017-11-16 |
2020-08-20 |
Amgen Inc |
Autoinyector con deteccion de detencion y punto final.
|
EP3746478A4
(en)
*
|
2018-01-29 |
2022-01-19 |
The Regents of The University of California |
THERAPIES AND METHODS OF TREATMENT OF TLR2-MEDIATED DISEASES AND DISORDERS
|
KR102652133B1
(ko)
*
|
2018-02-01 |
2024-03-29 |
베이징 카윈 테크놀로지 쉐어-홀딩 컴퍼니 리미티드 |
IL-4Rα 항체 및 그 용도
|
CN113150146B
(zh)
*
|
2018-02-01 |
2022-07-12 |
北京凯因科技股份有限公司 |
IL-4Rα抗体及其用途
|
MA52186A
(fr)
|
2018-03-26 |
2021-02-17 |
Amgen Inc |
Glycoformes afucosylées totales d'anticorps produits en culture cellulaire
|
EP3793597A1
(en)
|
2018-05-13 |
2021-03-24 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating atopic dermatitis by administering an il-4r inhibitor
|
CN110540590B
(zh)
*
|
2018-05-29 |
2023-08-18 |
康诺亚生物医药科技(成都)有限公司 |
一种自免疫抑制物的开发和应用
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
EP3826701A1
(en)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
US20210228815A1
(en)
|
2018-07-24 |
2021-07-29 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
EP3829692A1
(en)
|
2018-07-31 |
2021-06-09 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
CN110872349A
(zh)
*
|
2018-09-04 |
2020-03-10 |
三生国健药业(上海)股份有限公司 |
结合人il-4r的抗体、其制备方法和用途
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
AU2019350660A1
(en)
|
2018-09-28 |
2021-03-18 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
AR116679A1
(es)
|
2018-10-02 |
2021-06-02 |
Amgen Inc |
Sistemas de inyección para la administración de fármacos con transmisión de fuerza interna
|
EP3860686A1
(en)
|
2018-10-05 |
2021-08-11 |
Amgen Inc. |
Drug delivery device having dose indicator
|
CA3109988A1
(en)
|
2018-10-15 |
2020-04-23 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
SG11202103800RA
(en)
|
2018-10-15 |
2021-05-28 |
Amgen Inc |
Drug delivery device having damping mechanism
|
MA54057A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
|
WO2020092056A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial needle retraction
|
EP3873566A1
(en)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
CN111494625B
(zh)
|
2018-12-25 |
2022-06-21 |
江苏荃信生物医药股份有限公司 |
用于治疗il-4和/或il-13介导的信号转导相关的疾病的药物组合物
|
AU2020231343A1
(en)
|
2019-03-06 |
2021-10-21 |
Regeneron Pharmaceuticals, Inc. |
IL-4/IL-13 pathway inhibitors for enhanced efficacy in treating cancer
|
CN111686247B
(zh)
*
|
2019-03-13 |
2022-07-29 |
苏州康乃德生物医药有限公司 |
包含人白介素-4受体α的抗体的液体组合物
|
AU2020240132A1
(en)
|
2019-03-21 |
2021-09-16 |
Regeneron Pharmaceuticals, Inc. |
Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy
|
US20220160972A1
(en)
|
2019-04-24 |
2022-05-26 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
CA3147068A1
(en)
|
2019-08-05 |
2021-02-11 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonist
|
SG11202113310UA
(en)
|
2019-08-05 |
2021-12-30 |
Regeneron Pharma |
Methods for treating atopic dermatitis by administering an il-4r antagonist
|
CA3148261A1
(en)
|
2019-08-23 |
2021-03-04 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
WO2021062372A1
(en)
|
2019-09-26 |
2021-04-01 |
Amgen Inc. |
Methods of producing antibody compositions
|
KR20220158821A
(ko)
|
2020-03-27 |
2022-12-01 |
리제너론 파아마슈티컬스, 인크. |
Il-4r 길항제를 투여함에 의해 아토피 피부염을 치료하기 위한 방법
|
CN113527485A
(zh)
*
|
2020-04-17 |
2021-10-22 |
上海麦济生物技术有限公司 |
抗人白细胞介素-4受体α抗体及其制备方法和应用
|
EP4153300A1
(en)
|
2020-05-22 |
2023-03-29 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor
|
EP4162257A1
(en)
|
2020-06-04 |
2023-04-12 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
CN117327181A
(zh)
*
|
2020-06-22 |
2024-01-02 |
南京融捷康生物科技有限公司 |
抗IL-4Rα的单域抗体以及应用和药物
|
EP4229080A1
(en)
|
2020-10-15 |
2023-08-23 |
Amgen Inc. |
Relative unpaired glycans in antibody production methods
|
KR20230130681A
(ko)
|
2021-01-08 |
2023-09-12 |
리제너론 파아마슈티컬스, 인크. |
Il-4r 길항제 투여에 의한 땅콩 알레르기를 치료하는방법 및 땅콩 알레르기원 특이적 면역치료를 강화하는 방법
|
WO2022246055A1
(en)
|
2021-05-21 |
2022-11-24 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
EP4352094A1
(en)
|
2021-06-07 |
2024-04-17 |
Amgen Inc. |
Using fucosidase to control afucosylation level of glycosylated proteins
|
IL310962A
(en)
|
2021-08-23 |
2024-04-01 |
Regeneron Pharma |
Methods for treating atopic dermatitis by administering an IL-4R antagonist
|
WO2023059607A1
(en)
|
2021-10-05 |
2023-04-13 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
WO2023085978A1
(en)
*
|
2021-11-11 |
2023-05-19 |
Joint Stock Company «Biocad» |
Monoclonal antibody or antigen-binding fragment thereof that specifically binds to il-4ra, and use thereof
|
US20230220089A1
(en)
|
2021-12-30 |
2023-07-13 |
Regeneron Pharmaceuticals, Inc. |
Methods for attenuating atopic march by administering an il-4/il-13 antagonist
|
WO2023215750A2
(en)
|
2022-05-02 |
2023-11-09 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing lipase activity
|
WO2023215267A1
(en)
|
2022-05-02 |
2023-11-09 |
Regeneron Pharmaceuticals, Inc. |
Anti-interleukin-4 receptor (il-4r) antibody formulations
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
WO2024011251A1
(en)
|
2022-07-08 |
2024-01-11 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating eosinophilic esophagitis in pediatric by administering an il-4r antagonist
|